Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 avr. 2012 07h00 HE | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Announces Grant of New U.S. Patent Covering Sapacitabine

BERKELEY HEIGHTS, N.J., April 17, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP); (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...
04 avr. 2012 09h00 HE | Source: Bio Green Med Solution, Inc.

Personalized Medicine and Combination Potential of Cyclacel's Sapacitabine Highlighted at AACR

BERKELEY HEIGHTS, N.J., April 4, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP); (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...
02 avr. 2012 14h00 HE | Source: Bio Green Med Solution, Inc.

Cyclacel's Novel Polo-Like Kinase 1 (Plk1) Inhibitors Highlighted at AACR

BERKELEY HEIGHTS, N.J., April 2, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies...
29 mars 2012 16h01 HE | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results

BERKELEY HEIGHTS, N.J., March 29, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today its financial results and business...
26 mars 2012 16h30 HE | Source: Bio Green Med Solution, Inc.

Cyclacel to Announce Year-End and Fourth Quarter 2011 Financial Results and Multiple Presentations at the Upcoming AACR Conference

BERKELEY HEIGHTS, N.J., March 26, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today announced upcoming corporate events. Year...
22 mars 2012 16h30 HE | Source: Bio Green Med Solution, Inc.

Cyclacel Announces $3.0 Million Financing to Fund Ongoing Litigation Expenses on Certain Intellectual Property

BERKELEY HEIGHTS, N.J., March 22, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), today announced that the Company entered into a...
13 févr. 2012 07h00 HE | Source: Bio Green Med Solution, Inc.

Cyclacel Provides Update on Clinical Progress With Sapacitabine as Second Line Therapy in Older Patients With Myelodysplastic Syndromes

BERKELEY HEIGHTS, N.J., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), announced today new topline response data from an...
06 févr. 2012 07h00 HE | Source: Bio Green Med Solution, Inc.

Cyclacel to Present at Upcoming Investor Conferences

BERKELEY HEIGHTS, N.J., Feb. 6, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today that Spiro Rombotis, President and...
11 janv. 2012 12h15 HE | Source: Bio Green Med Solution, Inc.

Cyclacel Provides Corporate Update at OneMedForum Conference

BERKELEY HEIGHTS, N.J., Jan. 11, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today summarized its 2011 achievements and set forth...
06 janv. 2012 07h00 HE | Source: Bio Green Med Solution, Inc.

Cyclacel to Present at the 5th Annual OneMedForum in San Francisco

BERKELEY HEIGHTS, N.J., Jan. 6, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today announced that Spiro Rombotis, President and...

Page précédente